Our work suggests that circDLC1, a downstream target of KIAA1429, is a promising prognostic marker for HCC patients, and the circDLC1-HuR-MMP1 axis may serve as a potential therapeutic target for HCC treatment.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2020) studied this question.